CAHCardinal Health
Price
+60%1YEnd-of-day closes, not the intraday tick.
Survival is the story here: start there
Quality strong, hard red flags, price roughly fair, growth steady, the market undecided.
Cardinal Health, Inc., an Ohio corporation formed in 1979, is a global healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. We provide pharmaceuticals and medical products and cost-effective services and solutions that enhance the healthcare system and supply chain efficiency.
In the company’s own words · 10-K filed Aug 12, 2025 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Cardinal Health (CAH) reported revenue of $124.6B in H2 2026 (quarter ended Jun 30, 2026), up 127% from the same quarter a year earlier. That came with a gross margin of 4.1% and net income of $797M (0.6% of revenue). For the full year FY2026, revenue was $254.2B (+14% year on year) and net income $1.71B. Its largest segment in H2 2026 was Pharmaceutical And Specialty Solutions at $58.8B, 94% of the disclosed total, well ahead of GMPD at 5.0%. The next results filing is expected around Oct 29, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 11, 2026Cardinal Health Reports Fourth Quarter and Fiscal Year 2026 Results and Provides Fiscal Year 2027 Guidance.Earnings release · press release
- Aug 11, 2026On August 7, 2026, Cardinal Health, Inc., (the “Company”), Wells Fargo Bank, National Association (“WF”), as Administrative Agent, Wells Fargo Securities, LLC, BofA Securities, Inc., Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A., as Joint Lead Arrangers and Joint Bookrunners, and Goldman Sachs Bank USA and …Material agreement entered · Form 8-K
- Aug 5, 2026On August 4, 2026, Cardinal Health, Inc. (the “Company”) appointed Anita Zielinski as its Chief Accounting Officer of the Company, effective November 5, 2026.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
H2 2026 · $62.47BThe company’s own SEC segment disclosure.
- Pharmaceutical And Specialty Solutions$58.85B94%
- GMPD$3.13B5%
- All Other$497.0M1%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.